Inspire(US:INSP) Businesswire·2025-12-21 15:03Core Viewpoint - Inspire Medical Systems, Inc. is facing a federal securities class action due to allegations of misleading statements regarding the launch and demand for its Inspire V device, leading to significant financial losses for investors [3][5]. Group 1: Allegations and Legal Action - The complaint against Inspire Medical Systems claims that the company and its executives violated federal securities laws by making false or misleading statements about the market demand for the Inspire V device and the steps taken for its launch [3]. - Investors are reminded of the January 5, 2026 deadline to seek the role of lead plaintiff in the class action lawsuit [1][6]. Group 2: Launch Issues and Financial Impact - On August 4, 2025, Inspire Medical announced delays in the launch of the Inspire V device due to incomplete training and onboarding at treatment centers, as well as billing and reimbursement challenges [4]. - The company reported weak demand and excess inventory for the Inspire V, leading to a more than 80% cut in its 2025 earnings guidance [5]. - Following these announcements, Inspire's stock price plummeted over 32% in one day, from $129.95 to $87.91, resulting in a loss of approximately $1.2 billion in market capitalization [5].